Sign in
Taking people in United StatesNo phase

Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis

Key facts

Who runs it
University of Pittsburgh
Where
Baltimore, Indianapolis, and Pittsburgh, United StatesSee the 3 sites
Trial code
Status
Recruiting
People taking part
150 people, planned
Started
4 Jan 2022
Expected to end
30 Jun 2028
Type of study
Interventional
Treatments tested
  • Quantitative Sensory Test 1
  • Quantitative Sensory Test 2
  • Quantitative Sensory Test 3
Record updated
11 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Adult patients ≥ 18 years of age with definite CP undergoing decompressive invasive treatments (endoscopic therapy or surgery) to relieve main pancreatic duct obstruction due to stones and/or stricture for management of pain; Endoscopic therapy: Endoscopic Retrograde Cholangiopancreatography (ERCP) with pancreatic duct stone removal, stent placement, and/or stricture dilation, ± intraductal lithotripsy or Extracorporeal Shock Wave Lithotripsy (ESWL); Surgery: drainage procedures (Frey and Puestow operations)

Who cannot take part

  • Patients who have had endoscopic therapy within the past 12 months
  • Patients who have undergone prior pancreatic surgery
  • Patients who have resective surgical procedure planned (eg. Whipple procedure, Total Pancreatectomy)
  • Patients with chronic pain from conditions other than CP
  • Patients < 18 years of age
  • Patients with peripheral sensory deficits
  • Patients with known pregnancy at the time of study screening**; Note: Women who become pregnant during the course of the study can no longer participate in P-QST testing

Where in United States

  • Johns Hopkins Medical InstitutionsBaltimore, United StatesContact: Mahya Faghih, MDTaking people
  • Indiana University Medical CenterIndianapolis, United StatesContact: Suzette Schmidt, RNTaking people
  • University of Pittsburgh Medical CenterPittsburgh, United StatesContact: Anna E Phillips, MD, MSTaking people

About the trial

What the trial wants to find out

Abdominal pain in chronic pancreatitis (CP) affects up to 90% of patients during the course of their disease, and response to currently available therapies is suboptimal and unpredictable. The proposed clinical trial will evaluate the predictive capability of Pancreatic Quantitative Sensory Testing (P-QST) - a novel assessment of neurosensory phenotyping- for improvement in pain in patients with CP who are undergoing medically-indicated invasive treatment with endoscopic therapy or surgery.

The group in the trial

  • Pancreatic Quantitative Sensory Testing (P-QST)Treatment being tested

    Definite Chronic Pancreatitis patients undergoing decompressive invasive treatments (endoscopic therapy or surgery) to relieve main pancreatic duct obstruction due to stones and/or stricture for management of pain will undergo P-QST prior to clinically-indicated invasive treatment.

    Treatment: Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
11 September 2026